BNET Industries

CVS Corp.

CVS is in the Retail Industry

Market Cap:$43.9B
Last Fiscal Year Sales:$34.1M
  • Public
  • UK
Dow Jones Description

Corvus was established to identify assets or companies which are either underperforming against established investment criteria or are undervalued in their current form but can be otherwise acquired or tactically repositioned in order to realise potential value. The Corvus management team has the backing of a number international funding partners. Our considered approach over the last decade has created over $600 million of value for investors across a number of investments, either directly or via special purpose investment vehicles.

Number of Employees 18
Contact Information

Saint James's Street

London SW1A 1HB

www.corvus.com

(44) 8703896999

NAICS Code Pharmacies and Drug Stores: 446110

News & Analysis

cvs corp. and retail - All News and Analysis

  • In Recession CVS Seems Better Positioned Than Walgreen

    Seeking Alpha - 2009-02-10

    Geezeo.com submits: Retailers CVS Caremark Corporation (NYSE: CVS) and Walgreen Co. (NYSE: WAG) both experienced lower sales in January compared with December numbers. January saw the average monthly spending among Geezeo users fall 18% at Walgreen stores, compared to only a 4.92% decrease at...

    Tags: Retail, Geezeo, CVS Corp., Walgreen Co.

  • Testing the Efficient Market Hypothesis on CVS Caremark

    Seeking Alpha - 2009-01-05

    Saj Karsan submits: The Efficient Market Hypothesis (EMH) asserts that stock prices appropriately incorporate relevant information. As such, it isn't possible to generate market beating returns because the current price reflects available information. While it's not possible to completely disprove this theory (EMH theorists attribute the success of Warren Buffett...

    Tags: Retail, Saj Karsan, CVS Corp.

  • CVS Caremark: A Prescription for Profits?

    Seeking Alpha - 2008-12-25

    Paul Price submits: After recently closing on the acquisition of Longs Drugstores, [[CVS]] is now the largest integrated provider of pharmaceutical services. It fills over one billion prescriptions annually with over 6200 locations in 40 states. Its pharmacy benefits division is a leader in its field, nicely complementing the retail...

    Tags: Retail, Paul Price, CVS Corp.

  • The Short Selling Ban: Is CVS a Financial?

    Seeking Alpha - 2008-09-25

    Todd Sullivan submits: So, when did CVS CVS become classified as a financial? The SEC has added CVS to the "short selling ban" that was initially restricted to financial companies. The reason? CVS, one of the biggest US drugstore groups, said on Thursday it was added to the list...

    Tags: CVS Corp., US Market, Retail

  • Ackman Scores Big on Longs Drug Stores

    Seeking Alpha - 2008-08-13

    Lon Juricic submits: Bill Ackman just scored a major win with Longs Drug Stores LDG last night. CVS CVS announced that it would acquire the drug store chain for $71.50 per share, a significant premium to the $54.04 close. On August 5th, Ackman's Pershing Square disclosed an 8.8%...

    Tags: CVS Corp., Retail, Healthcare, Longs Drug Stores Corp.

Decision Makers

Name (plus bio) Position
Andrew Regan CEO
Julian Moore Executive Director
Joanna Barrett Executive
Michael Hirschfield Executive

Board of Directors

Name (plus bio) Position
Adrian Collins Chairman
Edward Hanson Board of Directors
Geoffrey Conway-Henderson Board of Directors
Graham Porter Board of Directors
Ian Tickler Board of Directors
John Leat Board of Directors
Richard Griffiths Board of Directors
Simon Fry Board of Directors

Andrew Regan, aged 40, joined the Board as Chief Executive of Corvus Capital Inc in September 2004 and over the following year took the company to record profits of 22.1 million in 2005. Andrew sold his original business to Hobson plc in 1991 where he became Chief Executive of Hobson which was listed on the LSE. In 1994 Hobson plc acquired the Co-operative Wholesale Society's food and drinks manufacturing operations and the enlarged Hobson business was eventually sold to Hillsdown Holdings plc for 154 million by way of a recommended takeover in 1996. In 1997 Andrew led an attempt, which subsequently lapsed, to gain control of the CWS in a 1.2 billion take-over bid. Andrew is based in Geneva and he has no other directorships.

Organization Position Status
Corvus Capital Inc CEO Current
Corvus Capital Inc Chief Executive Current

Julian is qualified as a chartered accountant with KPMG in Dublin. He has over seven years? experience in the finance industries in the UK, Ireland and South Africa. Julian is an executive director of Corvus Capital (SA) Holdings Limited, which is listed on the Johannesburg Stock Exchange, and is a consultant to CVS Management Limited and Corvus Capital Inc.

Organization Position Status
Corvus Capital Inc Executive Director Current
Diamondtech Inc Director Current

Organization Position Status
Corvus Capital Inc Executive Current
Diamondtech Inc Board of Directors Current
Corvus Capital Inc Director Current

Michael qualified as a chartered accountant with Peat Marwick in 1988. He has held senior management positions with a number of public and private companies and has advised Corvus Capital Inc on its Company Secretary Administration since February 2003 and joined the Board as a non-executive director in January 2007.

Organization Position Status
Corvus Capital Inc Executive Current
Corvus Capital Inc Board of Directors Current
Peat Marwick International Chartered Accountant Former

Organization Position Status
Corvus Capital Inc Chairman Current

Organization Position Status
Corvus Capital Inc Board of Directors Current

Organization Position Status
Corvus Capital Inc Board of Directors Current

Organization Position Status
Corvus Capital Inc Board of Directors Current

Organization Position Status
Corvus Capital Inc Board of Directors Current

Organization Position Status
Corvus Capital Inc Board of Directors Current

Organization Position Status
Corvus Capital Inc Board of Directors Current

Organization Position Status
Corvus Capital Inc Board of Directors Current
advertisement
CVS $31.18 -0.02 (-0.06% )
Volume 20,373,200
Shares Outstanding 1.4B
Market Cap 43.9B
Year High 38.27
Year Low 23.74
Earnings Per Share 2.46
P/E Ratio 12.6748
Dividend 0.305
Yield 0.978191
IndustryTop Rated
advertisement
Click Here
Presented by American Express